[
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-1",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#definitiongeneral506348",
    "clean_content": "Definition / general\n\n* Staging of mucosal melanoma of the head and neck refers to TNM staging of mucosal melanoma (MM) involving the nasal cavity, paranasal sinuses, oral cavity and less commonly, pharynx and larynx* Mucosal melanoma staging is distinct from staging systems used for cutaneous melanoma and carcinomas of those sites listed above"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-2",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#essentialfeatures506366",
    "clean_content": "Essential features\n\n* ~67% of mucosal melanomas arise in the sinonasal tract, 25% are found in the oral cavity and the remainder occur only sporadically in other mucosal sites of the head and neck* Even small cancers behave aggressively with high rates of recurrence and death* To reflect this aggressive behavior, primary cancers limited to the mucosa are considered T3 lesions* Anatomic extent criteria to define moderately advanced (T4a) and very advanced (T4b) disease are given below* AJCC 7th edition staging was sunset on December 31, 2017; as of January 1, 2018, use of the [8th edition](https://www.amazon.com/exec/obidos/ASIN/3319406175/pathologyoutl-20) is mandatory"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-3",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#icdcoding506367",
    "clean_content": "ICD coding\n\n* ICD-10\n  + [C44.301](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C43-C44/C44-/C44.301) - unspecified malignant neoplasm of skin of nose+ [C06.0](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C00-C14/C06-/C06.0) - malignant neoplasm of cheek mucosa+ [C05.9](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C00-C14/C05-/C05.9) - malignant neoplasm of palate, unspecified"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-4",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Primary tumor (pT)",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#primarytumorpt506349",
    "clean_content": "Primary tumor (pT)\n\n* **pT3**: tumors limited to the mucosa and immediately underlying soft tissue, regardless of thickness or greatest dimension; for example, polypoid nasal disease, pigmented or nonpigmented lesions of the oral cavity, pharynx or larynx* **pT4**: moderately advanced or very advanced disease\n    + **pT4a**: moderately advanced disease; tumor involving deep soft tissue, cartilage, bone or overlying skin+ **pT4b**: very advanced disease; tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space or mediastinal structures\n\n  \n**Notes**:\n\n* Compared with disease confined to the nasal cavity, sinus involvement confers significantly worse survival; based on this, further stratifying the T3 stage was highly prognostic (p < 0.001) with implications for a potential modification to the current TNM staging system ([J Neurol Surg B Skull Base 2022;84:307](37405239))"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-5",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Regional lymph nodes (pN)",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#regionallymphnodespn506350",
    "clean_content": "Regional lymph nodes (pN)\n\n* **pNX**: regional lymph nodes cannot be assessed* **pN0**: no regional lymph node metastases* **pN1**: regional lymph node metastases present\n\n  \n**Notes**:\n\n* Laterality of lymph node(s) with tumor is not applicable for mucosal melanoma* Size of largest nodal metastatic deposit is not applicable for mucosal melanoma* Extranodal extension (ENE) is not applicable for mucosal melanoma* Reference: [CAP: Protocol for the Examination of Specimens from Patients with Cancers of the Oral Cavity [Accessed 26 July 2024]](https://documents.cap.org/protocols/HN.Oral_4.2.0.0.REL_CAPCP.pdf)"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-6",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Distant metastasis (pM)",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#distantmetastasispm506351",
    "clean_content": "Distant metastasis (pM)\n\n* **cM0**: no distant metastasis* **cM1**: distant metastasis* **pM1**: distant metastasis, microscopically confirmed"
  },
  {
    "id": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt-7",
    "source_document": "staging-mucosal-melanoma-of-the-head--neck_47931_1750166915.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Prefixes",
    "url": "https://www.pathologyoutlines.com/topic/oralcavitystagingmucosalmelanoma.html#prefixes506370",
    "clean_content": "Prefixes\n\n* **c**: clinical (cTNM)* **p**: pathological (pTNM)* **y**: postneoadjuvant chemoradiation therapy (ycTNM or ypTNM)* **r**: recurrent tumor stage (rTNM)"
  }
]